Hussein RG, Al-Atrakji MQ. Impact of Infliximab Biosimilar (Ixifi®) Trough Levels on Disease Activity and Inflammatory Markers in Iraqi Rheumatoid Arthritis Patients. Al-Rafidain J Med Sci [Internet]. 2024 Sep. 14 [cited 2025 Oct. 23];7(1(Special):S36-40. Available from: https://ajms.iq/index.php/ALRAFIDAIN/article/view/906